Page last updated: 2024-08-20

fluocortolone and Acute Relapsing Multiple Sclerosis

fluocortolone has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grasser, A; Holsboer, F; Kümpfel, T; Rupprecht, R; Then Bergh, F; Trenkwalder, C	1

Trials

1 trial(s) available for fluocortolone and Acute Relapsing Multiple Sclerosis

Article	Year
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial. The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Antidepressive Agents; Disability Evaluation; Double-Blind Method; Drug Therapy, Combination; Female; Fluocortolone; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Moclobemide; Multiple Sclerosis, Relapsing-Remitting; Pituitary-Adrenal System; Reference Values	2001

Article

Year

Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.

The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:4

Topics: Adrenal Cortex Hormones; Adult; Antidepressive Agents; Disability Evaluation; Double-Blind Method; Drug Therapy, Combination; Female; Fluocortolone; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Moclobemide; Multiple Sclerosis, Relapsing-Remitting; Pituitary-Adrenal System; Reference Values

2001